Brighthouse Financial 배당 및 자사주 매입
배당 기준 점검 0/6
Brighthouse Financial 배당금을 지급한 기록이 없습니다.
핵심 정보
n/a
배당 수익률
1.2%
자사주 매입 수익률
| 총 주주 수익률 | 1.2% |
| 미래 배당 수익률 | 0% |
| 배당 성장률 | n/a |
| 다음 배당 지급일 | n/a |
| 배당락일 | n/a |
| 주당 배당금 | n/a |
| 배당 성향 | n/a |
최근 배당 및 자사주 매입 업데이트
Recent updates
BHF: Aquarian Go Private Deal Outcome Will Drive Next Upside Step
Analysts kept their $70.00 price target on Brighthouse Financial steady, making only modest adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E, following recent Street research that re-initiated coverage at a neutral stance. Analyst Commentary Bullish analysts see the reaffirmed US$70 price target as a signal that recent research supports the current valuation framework, even after fine tuning inputs such as discount rate, revenue growth, profit margins and assumed future P/E.BHF: Market Perform Stance Will Likely Cap Upside Before Take Private
Analysts keep their fair value estimate for Brighthouse Financial steady at $55.00. They cite recent Market Perform research that points to only modest tweaks in discount rate, revenue growth, profit margin, and forward P/E assumptions rather than a material shift in the investment case.BHF: Aquarian Go Private Outcome Will Drive Next Leg Of Upside
Narrative Update: Brighthouse Financial Analysts have adjusted their outlook on Brighthouse Financial, trimming the implied forward P/E in their models and revisiting assumptions on discount rate, revenue growth, and profit margin. Street research, including a downgrade to Equal Weight with an unchanged $65 price target and a Market Perform re-initiation, reflects a view that the Aquarian transaction and the possibility of the company going private are already well reflected in the current valuation and price targets.Brighthouse Financial: A Deal-Driven Opportunity, Not A Long-Term Compounder
Summary Brighthouse Financial is now an event-driven arbitrage play, anchored by Aquarian Capital's $70/share acquisition offer. BHF trades at a deep 0.5x P/B discount, reflecting structural risks, regulatory uncertainty, and skepticism about long-term value outside the pending deal. Record 2025 annuity sales and a 456% RBC ratio highlight operational strength, but high leverage and volatile earnings underscore balance sheet sensitivity. The arbitrage opportunity offers a potential 14% upside but is constrained by regulatory approval risks and weak organic growth prospects. Read the full article on Seeking AlphaBHF: Aquarian Take Private Path Will Likely Keep Risk Return Balanced
Analysts have trimmed their outlook for Brighthouse Financial, with the consensus price target moving from $65 to $55. They see the Aquarian deal as already reflected in the valuation and now expect a more measured risk and return profile following the downgrade to Equal Weight.BHF: Aquarian Take-Private And Sector Headwinds Will Shape 2026 Outlook
Narrative Update on Brighthouse Financial The analyst price target for Brighthouse Financial has been reaffirmed at $65, as analysts view the Aquarian deal as already reflected in the valuation and expect the transaction to proceed with Brighthouse ultimately being taken private. Analyst Commentary Recent commentary on Brighthouse Financial centers on how fully the Aquarian transaction is reflected in the current share price, as well as broader themes like capital strength, cash generation, and sector consolidation.BHF: Aquarian Take Private Scenario Will Anchor Upside Case
Analysts have trimmed their fair value estimate for Brighthouse Financial from $72.00 to $70.00, citing updated assumptions on growth, margins, and discount rates, as well as a more neutral stance following recent views that the pending Aquarian transaction and a potential take private outcome are already reflected in the stock. Analyst Commentary Recent commentary has shifted to a more balanced stance on Brighthouse Financial, with some prior optimism now tempered by the view that key corporate events are already captured in the current share price.BHF: Aquarian Take-Private Scenario Will Likely Cap Future Upside Potential
Narrative Update Analysts have kept their $65 price target for Brighthouse Financial unchanged, citing that the expected Aquarian transaction and updated assumptions around higher projected revenue growth, improved profit margins, and a lower future P/E are already reflected in the valuation. Analyst Commentary Bearish analysts are taking a more cautious stance on Brighthouse Financial, even with the Aquarian transaction and a US$65 price target already on the table.BHF: Aquarian Takeout And Sector Headwinds Will Shape 2026 Risk Reward
Analysts held their fair value estimate for Brighthouse Financial steady at $65.50, noting that recent price target actions and downgrades reflect a view that the announced Aquarian takeout at $70 per share and the expected completion of that transaction are already well reflected in the stock. Analyst Commentary Recent research suggests that most of the value from the proposed Aquarian acquisition is already reflected in Brighthouse Financial's share price, with analysts focusing less on near term upside and more on deal completion and relative opportunity versus other names.BHF: Take Private Spread And Sector Headwinds Will Shape 2026 Returns
Analysts have nudged their 12 month price target for Brighthouse Financial slightly higher to about US$65.50. This reflects a balanced view that incorporates the Aquarian take private deal, more neutral ratings, and only modest tweaks to long term growth, margin, and P/E assumptions.BHF: Aquarian Take Private Terms And Sector Headwinds Will Shape Returns
Narrative Update Opening Analysts have kept their price target for Brighthouse Financial steady at $65.50, with the unchanged valuation reflecting expectations that the Aquarian take private deal and recent rating shifts to more neutral stances already capture the key risks and potential rewards in the shares. Analyst Commentary Recent research updates around Brighthouse Financial cluster around the Aquarian acquisition at $70 per share, with several firms resetting ratings closer to neutral as they see the deal terms and current trading levels already reflecting much of the expected outcome.BHF: Deal-Dependent Upside Will Likely Offer Limited Future Return Potential
Analysts have raised their fair value estimate for Brighthouse Financial to $55 from $42 as they factor in the proposed $70 per share takeout, a lower perceived risk profile reflected in a reduced discount rate, and somewhat more modest long term growth and profitability assumptions alongside higher expected exit multiples. Analyst Commentary Recent Street research reflects a more balanced, and in some cases cautious, stance on Brighthouse Financial following the announced acquisition, with several bearish analysts highlighting limited upside to the agreed takeout valuation and execution risk around the closing of the deal.BHF: Aquarian Buyout Price And Deal Execution Will Shape Future Return Profile
Analysts have trimmed their price target on Brighthouse Financial by about $1 to roughly $66 per share, reflecting the stock's limited upside following the agreed $70 per share acquisition by Aquarian and the view that other names now offer more attractive intermediate term return potential, despite supportive earnings and claims trends. Analyst Commentary Street research following the Aquarian buyout announcement reflects a more balanced stance on Brighthouse Financial, with most commentary emphasizing limited upside to the agreed transaction price and the shift in focus toward execution through closing rather than long term standalone growth.BHF: Takeover Agreement And Acquisition Uncertainties Will Define Returns Ahead
Brighthouse Financial’s analyst price target has been raised from approximately $60.89 to $66.14 per share. Analysts cite expectations for stronger revenue growth and lower discount rates, following recent takeover activity and market reassessment.BHF: Acquisition Agreement And Earnings Tailwinds Will Shape Risk And Opportunity
Analysts have raised their fair value estimate for Brighthouse Financial from $56.22 to $60.89 per share. This change reflects improved acquisition prospects and anticipated earnings tailwinds.Aging Population And Digital Transformation Will Expand Market Opportunities
Analysts have reduced EPS estimates for Brighthouse Financial amid sector-wide headwinds and declining variable investment income, but ongoing buyout interest and potential acquisition premiums provide support, resulting in an unchanged consensus price target of $56.22. Analyst Commentary Bearish analysts cite continued fee and spread headwinds and have reduced EPS estimates for Brighthouse Financial and the broader life insurance sector.US Aging Demographics Will Boost Annuity Demand
Strong demand for retirement solutions and product innovation are driving revenue growth, sales volume, and market competitiveness for Brighthouse.Brighthouse Financial: Capital Challenges Limit Upside (Rating Downgrade)
Summary Shares of Brighthouse Financial surged on M&A rumors but pulled back due to mixed results and unclear strategic direction; I recommend selling shares. Private equity interest in BHF is uncertain due to its complex annuity portfolio and capital constraints, and the best case is likely a minority stake sale. BHF's capital generation issues and statutory earnings power are concerning, with limited prospects for meaningful dividends to the holding company until 2027. Despite solid non-GAAP earnings, the company's underwhelming capital generation and complex financial maneuvers make shares unattractive; I prefer stocks with higher capital return yields like Jackson. Read the full article on Seeking AlphaBrighthouse Financial: Capital Generation Remains Concerning
Summary Brighthouse Financial has had a disappointing performance, gaining 12% but underperforming the market, with volatile shares due to mixed quarterly results. BHF's capital generation remains problematic, constraining potential returns. Management is addressing issues, but uncertainty persists, impacting profitability and growth. The company is considering reinsurance to improve its capital ratio, trading off short-term profitability for capital strength. Despite buybacks reducing share count by 7.6%, BHF's capital return capacity is less attractive compared to peers like Jackson and Equitable. I maintain a "hold" rating. Read the full article on Seeking AlphaBrighthouse: Weak Capital Limits Upside (Rating Downgrade)
Summary Brighthouse Financial stock has underperformed compared to competitors like Jackson Financial and Equitable, losing 19% in the past year after a series of weak results. Brighthouse reported disappointing Q2 results, with a significant loss on a statutory basis, leaving it with too little capital. The company's cash flow will be constrained due to lower capital, impacting its ability to sell new products and return capital to shareholders. With better alternatives elsewhere, investors should avoid BHF, even as strong holdco liquidity may limit downside. Read the full article on Seeking AlphaBrighthouse: A Weak Q1, But Headwinds Are Reflected In Valuation
Summary Brighthouse Financial shares plunged 10% after disappointing quarterly results, leaving them only marginally up from a year ago. The company reported a profit from an adjusted loss by excluding actuarial adjustments, but investors are concerned about the reinsurance rate increase. Despite strong sales momentum, capital consumption from SHIELD growth is a challenge for the company. Even with lessened free cash flow, shares are relatively cheap and buybacks will continue to be meaningful. Read the full article on Seeking AlphaBrighthouse: Positioned For 2024 Capital Improvement
Summary Brighthouse Financial shares have underperformed this past year due to capital performance and business complexity. The company reported adjusted earnings of $4.18 per share in Q3, up 3% from last year. Concerns about capital performance have weighed on the share price, but improvements are expected in 2024 given a reinsurance transaction and market movements. Read the full article on Seeking AlphaEarnings Miss: Brighthouse Financial, Inc. Missed EPS And Analysts Are Revising Their Forecasts
As you might know, Brighthouse Financial, Inc. ( NASDAQ:BHF ) recently reported its first-quarter numbers. Things were...지급의 안정성과 성장
배당 데이터 가져오는 중
안정적인 배당: 과거에 BHF 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.
배당금 증가: BHF 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.
배당 수익률 vs 시장
| Brighthouse Financial 배당 수익률 vs 시장 |
|---|
| 구분 | 배당 수익률 |
|---|---|
| 회사 (BHF) | n/a |
| 시장 하위 25% (US) | 1.4% |
| 시장 상위 25% (US) | 4.3% |
| 업계 평균 (Insurance) | 2.6% |
| 분석가 예측 (BHF) (최대 3년) | 0% |
주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 BHF 의 배당 수익률을 평가할 수 없습니다.
고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 BHF 의 배당 수익률을 평가할 수 없습니다.
주주 대상 이익 배당
수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 BHF 의 지급 비율을 계산하기에는 데이터가 부족합니다.
주주 현금 배당
현금 흐름 범위: BHF 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.
높은 배당을 제공하는 우량 기업 찾기
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/18 01:56 |
| 종가 | 2026/05/18 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Brighthouse Financial, Inc.는 19명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Tracy Dolin-Benguigui | Barclays |
| Tracy Dolin-Benguigui | Barclays |